Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
2.
J Biosci Bioeng ; 124(6): 611-617, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28728974

ABSTRACT

The genomes of actinomycetes encode many cryptic novel/useful bioactive compounds, but access to these cryptic secondary metabolites remains limited. Streptomyces avermitilis predominantly produces three polyketide antibiotics (avermectin, filipin, and oligomycin) but has the potential to produce more secondary metabolites based on the number of cryptic biosynthetic gene clusters. Here, we extensively investigated the metabolite profiles of a gene disruptant of AvaR3 (an autoregulator receptor homologue), which is involved in the pleiotropic regulation of antibiotic production and cell morphology. Unlike the wild-type strain, the avaR3 mutant accumulated compound 3 in the culture. The chemical structure of compound 3 was elucidated on the basis of various spectroscopic analyses, and was identified as phthoxazolin A, a cellulose synthesis inhibitor. Bioassays demonstrated that compound 3 exerts growth inhibitory activity against a broad range of plant pathogenic oomycetes. Moreover, unlike avermectin production, phthoxazolin A (3) production was negatively controlled by avenolide, a new type of autoregulator in streptomycetes, through the function of AvaR3. These results suggest that the genetic manipulation of autoregulator receptor homologues would be a valuable tool for the discovery of cryptic bioactive compounds.


Subject(s)
Bacterial Proteins/genetics , Fatty Alcohols/metabolism , Oxazoles/metabolism , Polyunsaturated Alkamides/metabolism , Streptomyces/genetics , Streptomyces/metabolism , Anti-Bacterial Agents/biosynthesis , Anti-Bacterial Agents/metabolism , Bacterial Proteins/metabolism , Biological Assay , Fatty Alcohols/chemistry , Fatty Alcohols/isolation & purification , Fatty Alcohols/pharmacology , Gene Expression Regulation, Bacterial , Ivermectin/analogs & derivatives , Ivermectin/chemistry , Ivermectin/metabolism , Multigene Family , Oomycetes/drug effects , Oxazoles/chemistry , Oxazoles/isolation & purification , Oxazoles/pharmacology , Polyunsaturated Alkamides/chemistry , Polyunsaturated Alkamides/isolation & purification , Polyunsaturated Alkamides/pharmacology , Secondary Metabolism/genetics , Streptomyces/cytology
3.
Appl Microbiol Biotechnol ; 100(22): 9581-9591, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27541747

ABSTRACT

Streptomyces hormones, sometimes called as autoregulators, are important signaling molecules to trigger secondary metabolism across many Streptomyces species. We recently identified a butenolide-type autoregulator (termed avenolide) as a new class of Streptomyces hormone from Streptomyces avermitilis that produces important anthelmintic agent avermectin. Avenolide triggers the production of avermectin with minimum effective concentration of nanomolar. Here, we describe the characterization of avaR1 encoding an avenolide receptor in the regulation of avermectin production and avenolide biosynthesis. The disruption of avaR1 resulted in transcriptional derepression of avenolide biosynthetic gene with an increase in avenolide production, with no change in the avermectin production profile. Moreover, the avaR1 mutant showed increased transcription of avaR1. Together with clear DNA-binding capacity of AvaR1 toward avaR1 upstream region, it suggests that AvaR1 negatively controls the expression of avaR1 through the direct binding to the promoter region of avaR1. These findings revealed that the avenolide receptor AvaR1 functions as a transcriptional repressor for avenolide biosynthesis and its own synthesis.


Subject(s)
4-Butyrolactone/analogs & derivatives , Bacterial Proteins/metabolism , Gene Expression Regulation, Bacterial , Ivermectin/analogs & derivatives , Receptors, Cell Surface/metabolism , Repressor Proteins/metabolism , Streptomyces/metabolism , 4-Butyrolactone/metabolism , Bacterial Proteins/genetics , Gene Knockout Techniques , Ivermectin/metabolism , Receptors, Cell Surface/genetics , Repressor Proteins/genetics , Streptomyces/genetics , Transcription, Genetic
4.
Appl Environ Microbiol ; 80(16): 5028-36, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24907338

ABSTRACT

Mycosporines and mycosporine-like amino acids (MAAs), including shinorine (mycosporine-glycine-serine) and porphyra-334 (mycosporine-glycine-threonine), are UV-absorbing compounds produced by cyanobacteria, fungi, and marine micro- and macroalgae. These MAAs have the ability to protect these organisms from damage by environmental UV radiation. Although no reports have described the production of MAAs and the corresponding genes involved in MAA biosynthesis from Gram-positive bacteria to date, genome mining of the Gram-positive bacterial database revealed that two microorganisms belonging to the order Actinomycetales, Actinosynnema mirum DSM 43827 and Pseudonocardia sp. strain P1, possess a gene cluster homologous to the biosynthetic gene clusters identified from cyanobacteria. When the two strains were grown in liquid culture, Pseudonocardia sp. accumulated a very small amount of MAA-like compound in a medium-dependent manner, whereas A. mirum did not produce MAAs under any culture conditions, indicating that the biosynthetic gene cluster of A. mirum was in a cryptic state in this microorganism. In order to characterize these biosynthetic gene clusters, each biosynthetic gene cluster was heterologously expressed in an engineered host, Streptomyces avermitilis SUKA22. Since the resultant transformants carrying the entire biosynthetic gene cluster controlled by an alternative promoter produced mainly shinorine, this is the first confirmation of a biosynthetic gene cluster for MAA from Gram-positive bacteria. Furthermore, S. avermitilis SUKA22 transformants carrying the biosynthetic gene cluster for MAA of A. mirum accumulated not only shinorine and porphyra-334 but also a novel MAA. Structure elucidation revealed that the novel MAA is mycosporine-glycine-alanine, which substitutes l-alanine for the l-serine of shinorine.


Subject(s)
Actinomycetales/genetics , Amino Acids/biosynthesis , Bacterial Proteins/genetics , Gene Expression , Glycine/analogs & derivatives , Multigene Family , Streptomyces/metabolism , Actinomycetales/metabolism , Bacterial Proteins/metabolism , Cyclohexanones , Cyclohexylamines , Glycine/biosynthesis , Streptomyces/genetics
5.
J Antibiot (Tokyo) ; 64(12): 781-7, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21989459

ABSTRACT

The first total synthesis of extracellular factor, "Avenolide", in Streptomyces avermitilis has been achieved using a convergent approach. The stereogenic centers in two key segments were installed using Sharpless epoxidation and dihydroxylation. This synthetic study allowed the determination of the absolute configuration of avenolide as 4S,10R, and yielded important information on its structure-activity relationship.


Subject(s)
4-Butyrolactone/analogs & derivatives , Streptomyces/metabolism , 4-Butyrolactone/biosynthesis , 4-Butyrolactone/chemical synthesis , 4-Butyrolactone/chemistry , 4-Butyrolactone/metabolism , Magnetic Resonance Spectroscopy , Spectrometry, Mass, Fast Atom Bombardment , Spectrophotometry, Infrared , Stereoisomerism , Streptomyces/chemistry , Structure-Activity Relationship
6.
Proc Natl Acad Sci U S A ; 108(39): 16410-5, 2011 Sep 27.
Article in English | MEDLINE | ID: mdl-21930904

ABSTRACT

Gram-positive bacteria of the genus Streptomyces are industrially important microorganisms, producing >70% of commercially important antibiotics. The production of these compounds is often regulated by low-molecular-weight bacterial hormones called autoregulators. Although 60% of Streptomyces strains may use γ-butyrolactone-type molecules as autoregulators and some use furan-type molecules, little is known about the signaling molecules used to regulate antibiotic production in many other members of this genus. Here, we purified a signaling molecule (avenolide) from Streptomyces avermitilis--the producer of the important anthelmintic agent avermectin with annual world sales of $850 million--and determined its structure, including stereochemistry, by spectroscopic analysis and chemical synthesis as (4S,10R)-10-hydroxy-10-methyl-9-oxo-dodec-2-en-1,4-olide, a class of Streptomyces autoregulator. Avenolide is essential for eliciting avermectin production and is effective at nanomolar concentrations with a minimum effective concentration of 4 nM. The aco gene of S. avermitilis, which encodes an acyl-CoA oxidase, is required for avenolide biosynthesis, and homologs are also present in Streptomyces fradiae, Streptomyces ghanaensis, and Streptomyces griseoauranticus, suggesting that butenolide-type autoregulators may represent a widespread and another class of Streptomyces autoregulator involved in regulating antibiotic production.


Subject(s)
Anthelmintics/metabolism , Hormones/metabolism , Ivermectin/analogs & derivatives , Streptomyces/metabolism , Culture Media , Hormones/chemistry , Ivermectin/metabolism , Ligands , Mass Spectrometry , Nuclear Magnetic Resonance, Biomolecular , Solvents
7.
Microbiology (Reading) ; 157(Pt 8): 2266-2275, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21622528

ABSTRACT

The γ-butyrolactone autoregulator receptor has been shown to control secondary metabolism and/or morphological differentiation across many Streptomyces species. Streptomyces avermitilis produces an important anthelmintic agent (avermectin) and two further polyketide antibiotics, filipin and oligomycin. Genomic analysis of S. avermitilis revealed that this micro-organism has the clustered putative autoregulator receptor genes distant from the antibiotic biosynthetic gene clusters. Here, we describe the characterization of avaR3, one of the clustered receptor genes, which encodes a protein containing an extra stretch of amino acid residues that has not been found in the family of autoregulator receptors. Disruption of avaR3 resulted in markedly decreased production of avermectins, with delayed expression of avermectin biosynthetic genes, suggesting that AvaR3 positively controls the avermectin biosynthetic genes. Moreover, the disruption caused increased production of filipin without any changes in the transcriptional profile of the filipin biosynthetic genes, suggesting that filipin production is indirectly controlled by AvaR3. The avaR3 disruptant displayed fragmented growth in liquid culture and conditional morphological defects on solid medium. These findings demonstrated that AvaR3 acts as a global regulator that controls antibiotic production and cell morphology.


Subject(s)
Anti-Bacterial Agents/biosynthesis , Bacterial Proteins/metabolism , Filipin/biosynthesis , Gene Expression Regulation, Bacterial , Ivermectin/analogs & derivatives , Streptomyces/cytology , Streptomyces/metabolism , Bacterial Proteins/genetics , Biosynthetic Pathways/genetics , Culture Media/chemistry , Gene Expression Profiling , Gene Knockout Techniques , Genes, Bacterial , Ivermectin/metabolism , Multigene Family , Mutagenesis, Insertional , Streptomyces/growth & development
SELECTION OF CITATIONS
SEARCH DETAIL
...